GlaxoSmithKline (GSK) has announced plans to cut more than 1,200 jobs at its Belgium-based facilities as part of a broader $2.5 billion restructuring initiative aimed at streamlining operations and accelerating growth. The pharmaceutical giant’s decision marks a significant development in its ongoing transformation strategy, reflecting mounting pressure to boost efficiency amid a rapidly evolving healthcare landscape. The planned layoffs at multiple sites underscore GSK’s commitment to reshaping its footprint in Europe while pursuing intensified investment in innovation and pipeline advancement.
GSK’s Strategic Restructuring Targets Belgium Operations Amid Industry Challenges
GSK is accelerating its transformation journey with plans to reduce its workforce by over 1,200 employees across its Belgium operations. This move is part of a broader $2.5 billion restructuring program aimed at streamlining operations, reducing costs, and bolstering competitiveness amid…
—-
Author : Mia Garcia
Publish date : 2026-10-17 15:34:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8
